quantisnow
FeedTopReportsPricing
⌘K
Live feed
04:45:00·127d
PRRelease
Bristol-Myers Squibb Company logo
BioNTech SE logo
CureVac N.V. logo

BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field

BMY· Bristol-Myers Squibb CompanyBNTX· BioNTech SECVAC· CureVac N.V.
Health Care
Original source

Companies

  • BMY
    Bristol-Myers Squibb Company
    Health Care
  • BNTX
    BioNTech SE
    Health Care
  • CVAC
    CureVac N.V.
    Health Care

Recent analyst ratings

  • Feb 25BMYUpdateRBC Capital Mkts$60.00
  • Feb 20BMYUpdateBarclays$75.00
  • Feb 2BNTXUpdateLeerink Partners$113.00
  • Jan 16BNTXUpdateGoldman$142.00
  • Jan 7BMYUpdateUBS$65.00
  • Dec 15BMYUpdateBofA Securities$61.00

Related

  • PR2h
    Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company
  • INSIDER17h
    Chief Operating Officer Poetting Sierk sold $5,527,960 worth of Ordinary Shares (50,000 units at $110.56) (SEC Form 4)
  • PR1d
    Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration
  • PR3d
    Foundation Medicine Expands Existing Collaboration with Bristol Myers Squibb to Develop a Next-Generation Sequencing Companion Diagnostic to Identify Patients with Homozygous MTAP Deletion
  • PR3d
    BioNTech to Report First Quarter 2026 Financial Results and Corporate Update on May 5, 2026
  • PR4d
    Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer
  • SEC6d
    SEC Form DEFA14A filed by Bristol-Myers Squibb Company
  • PR9d
    Beeline Medicines Debuts to Deliver Category-Leading Precision Therapies for People Living with Autoimmune and Inflammatory Diseases
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022